Literature DB >> 8439223

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

J Stamler1, R Stamler, J D Neaton.   

Abstract

The National High Blood Pressure Education Program (NHBPEP) was launched 20 years ago based on data from population studies and clinical trials that showed high blood pressure (HBP) was a major unsolved--but soluble--mass public health problem. The present review summarizes recent data from US prospective population studies on blood pressure--systolic (SBP), diastolic (DBP)--and cardiovascular risk. The outcome variables include blood pressure-related risks, primarily incidence and mortality from coronary heart disease, stroke, other and all cardiovascular diseases (CVD); also cardiac abnormalities (roentgenographic, electrocardiographic, echocardiographic); also, all-cause mortality and life expectancy. Data accrued during the past 20 years confirm that SBP and DBP have continuous, graded, strong, independent, etiologically significant relationships to the outcome variables. These relationships are documented for young, middle-aged, and older men and for middle-aged and older women of varying socioeconomic backgrounds and ethnicity. Among persons aged 35 years or more, most have SBP/DBP above optimal (< 120/< 80 mm Hg); hence, they are at increased CVD risk, ie, the blood pressure problem involves most of the population, not only the substantial minority with clinical HBP. For middle-aged and older persons, SBP relates even more strongly to risk than DBP; at every DBP level, higher SBP results in greater CVD risk and curtailment of life expectancy. A great potential exists for improved health and increased longevity through control of the blood pressure problem. Its realization requires a strategy combining population wide and high-risk approaches, the former to prevent rise of blood pressure with age and to achieve primary prevention of HBP by nutritional-hygienic means; the latter to enhance detection, treatment, and control of HBP. The newly expanded goals of the NHBPEP, aimed at implementing this broader strategy for the solution of the blood pressure problem, merit active support from physicians and all health professionals.

Entities:  

Mesh:

Year:  1993        PMID: 8439223     DOI: 10.1001/archinte.153.5.598

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  263 in total

Review 1.  The role of diet in the prevention and treatment of hypertension.

Authors:  L J Appel
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

Review 2.  Quality of life with nonpharmacologic treatment of hypertension.

Authors:  J P Roel; C L Hildebrant; R H Grimm
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 3.  Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.

Authors:  R Padwal; S E Straus; F A McAlister
Journal:  BMJ       Date:  2001-04-21

Review 4.  Systolic versus diastolic blood pressure versus pulse pressure.

Authors:  William B White
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

5.  Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.

Authors:  Le Kang; Weijie Chen; Nicholas A Petrick; Brandon D Gallas
Journal:  Stat Med       Date:  2014-11-17       Impact factor: 2.373

Review 6.  Risk factor thresholds: their existence under scrutiny.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  2002-06-29

7.  Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium.

Authors:  Stephen Havas; Edward J Roccella; Claude Lenfant
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

Review 8.  Noncompliance with antihypertensive therapy. Economic consequences.

Authors:  T L Skaer; D A Sclar; L M Robison
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

9.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

10.  Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study.

Authors:  Cheryl A M Anderson; Lawrence J Appel; Nagako Okuda; Ian J Brown; Queenie Chan; Liancheng Zhao; Hirotsugu Ueshima; Hugo Kesteloot; Katsuyuki Miura; J David Curb; Katsushi Yoshita; Paul Elliott; Monica E Yamamoto; Jeremiah Stamler
Journal:  J Am Diet Assoc       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.